Resultados de la búsqueda 151-160 of 3649 for Amphotericin B

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG recommended high ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    standard surgery (ILND); B. neoadjuvant chemotherapy followed by standard ... B]. This Phase 3 study is designed to evaluate the specificity and ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG recommended high ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    standard surgery (ILND); B. neoadjuvant chemotherapy followed by standard surgery (ILND); or C. neoadjuvant chemoradiotherapy followed by standard surgery ...

  5. Chemotherapy for prostate cancer - Mayo Clinic

    Docetaxel and cabazitaxel belong to a group of chemotherapy drugs called taxanes. Derived from plants, taxanes work by stopping cancer cells from dividing into ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... B) current COG recommended high-risk therapy with the addition of a block of 131I-MIBG after the third Induction cycle; or C) current COG recommended high ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B ... (B+R) in patients with relapsed or resistant chronic lymphocytic leukemia.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    standard surgery (ILND); B. neoadjuvant chemotherapy followed by standard surgery (ILND); or C. neoadjuvant chemoradiotherapy followed by standard surgery ...

  9. Mayo Clinic Digestive Diseases Physician Update - April 2025

    Page 1.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...